The structure of the archaeal nuclease RecJ2 implicates its catalytic mechanism and inability to interact with GINS
Journal of Biological Chemistry · 2024
DOI: 10.1016/j.jbc.2024.107379 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biological Chemistry, 2024. Verfasst von Wei-Wei Wang und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China; Shanghai Syn…. Hauptthemen laut MEDLINE: Archaeal Proteins. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Bacterial RecJ exhibits 5'→3' exonuclease activity that is specific to ssDNA; however, archaeal RecJs show 5' or 3' exonuclease activity. The hyperthermophilic archaea Methanocaldococcus jannaschii encodes the 5'-exonuclease MjRecJ1 and the 3'-exonuclease MjRecJ2. In addition to nuclease activity, archaeal RecJ interacts with GINS, a structural subcomplex of the replicative DNA helicase complex. However, MjRecJ1 and MjRecJ2 do not interact with MjGINS. Here, we report the structural basis for the inability of the MjRecJ2 homologous dimer to interact with MjGINS and its efficient 3' hydrolysis polarity for short dinucleotides. Based on the crystal structure of MjRecJ2, we propose that the interaction surface of the MjRecJ2 dimer overlaps the potential interaction surface for MjGINS and blocks the formation of the MjRecJ2-GINS complex. Exposing the interaction surface of the MjRecJ2 dimer restores its interaction with MjGINS. The cocrystal structures of MjRecJ2 with substrate dideoxynucleotides or product dCMP/CMP show that MjRecJ2 has a short substrate binding patch, which is perpendicular to the longer patch of bacterial RecJ. Our results provide new insights into the function and diversification of archaeal RecJ/Cdc45 proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China; Shanghai Synchrotron Radiation Facility, Shanghai Advanced Research Institute, Chi…
- State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China.
- Shanghai Synchrotron Radiation Facility, Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai, China.
- State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China; SJTU Yazhou Bay Institute of Deepsea Sci-Tech, Sanya, China.
- Shanghai Synchrotron Radiation Facility, Shanghai Advanced Research Institute, Chinese Academy of Sciences, Shanghai, China; The Institute for Advanced Studies, Wuhan University, Wuhan, China.
- State Key Laboratory of Microbial Metabolism, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, China; SJTU Yazhou Bay Institute of Deepsea Sci-Tech, Sanya, China; Joint International R…
Zitieren
APA
Wang, W. W., Yi, G. S., Zhou, H., Zhao, Y. X., Wang, Q. S., He, J. H., Yu, F., Xiao, X., & Liu, X. P. (2024). The structure of the archaeal nuclease RecJ2 implicates its catalytic mechanism and inability to interact with GINS. Journal of Biological Chemistry. https://doi.org/10.1016/j.jbc.2024.107379
Vancouver
Wang WW, Yi GS, Zhou H, Zhao YX, Wang QS, He JH, et al. The structure of the archaeal nuclease RecJ2 implicates its catalytic mechanism and inability to interact with GINS. Journal of Biological Chemistry. 2024. doi:10.1016/j.jbc.2024.107379
BibTeX
@article{Wang2024,
author = {Wang, Wei-Wei and Yi, Gang-Shun and Zhou, Huan and Zhao, Yi-Xuan and Wang, Qi-Sheng and He, Jian-Hua and Yu, Feng and Xiao, Xiang and Liu, Xi-Peng},
title = {The structure of the archaeal nuclease RecJ2 implicates its catalytic mechanism and inability to interact with GINS},
journal = {Journal of Biological Chemistry},
year = {2024},
doi = {10.1016/j.jbc.2024.107379}
}
EUVIMED